Assignee
ATHEROGENICS INC
US·25 granted patents·5 pending applications·637 citations·filing 1998–2006
Top patents by PatentIndex Score
30 records- 0196US6670398B2Compounds and methods for treating transplant rejectionATHEROGENICS INC·Filed 2001·Granted Dec 30, 2003·63 cites·25 claims
- 0295US6147250ACompounds and methods for the inhibition of the expression of VCAM-1ATHEROGENICS INC·Filed 1998·Granted Nov 14, 2000·108 cites·9 claims
- 0395US6121319AMonoesters of probucol for the treatment of cardiovascular and inflammatory diseaseATHEROGENICS INC·Filed 1998·Granted Sep 19, 2000·107 cites·14 claims
- 0491US6617352B2Compounds and methods for the inhibition of the expression of VCAM-1ATHEROGENICS INC·Filed 2002·Granted Sep 9, 2003·25 cites·26 claims
- 0591US6608101B11, 3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disordersATHEROGENICS INC·Filed 2001·Granted Aug 19, 2003·53 cites·49 claims
- 0691US6602914B2Compounds and methods for the inhibition of the expression of VCAM-1ATHEROGENICS INC·Filed 2002·Granted Aug 5, 2003·24 cites·26 claims
- 0789US6852878B2Thioketals and thioethers for inhibiting the expression of VCAM-1ATHEROGENICS INC·Filed 2001·Granted Feb 8, 2005·30 cites·27 claims
- 0888US6887712B1Methods and compositions to lower plasma cholesterol levelsATHEROGENICS INC·Filed 1999·Granted May 3, 2005·53 cites·9 claims
- 0986US7247714B2Protection against oxidative stress and inflammation by a cytoprotective response elementATHEROGENICS INC·Filed 2002·Granted Jul 24, 2007·18 cites·20 claims
- 1086US6881860B2Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionalityATHEROGENICS INC·Filed 2001·Granted Apr 19, 2005·27 cites·33 claims
- 1186US6828447B2Compounds and methods for the inhibition of the expression of VCAM-1ATHEROGENICS INC·Filed 2002·Granted Dec 7, 2004·13 cites·26 claims
- 1286US6548699B1Compounds and methods for the inhibition of the expression of VCAM-1ATHEROGENICS INC·Filed 1999·Granted Apr 15, 2003·38 cites·68 claims
- 1385US7294737B2Process of preparing esters and ethers of probucol and derivatives thereofATHEROGENICS INC·Filed 2005·Granted Nov 13, 2007·5 cites·11 claims
- 1483US7371895B2Salt forms of poorly soluble probucol esters and ethersATHEROGENICS INC·Filed 2005·Granted May 13, 2008·5 cites·24 claims
- 1582US7375252B2Compounds and method for the inhibition of the expression of VCAM-1ATHEROGENICS INC·Filed 2002·Granted May 20, 2008·9 cites·12 claims
- 1681US7087645B2Compounds and methods for treating transplant rejectionATHEROGENICS INC·Filed 2003·Granted Aug 8, 2006·9 cites·24 claims
- 1778US7094801B2Chalcone derivatives and their use to treat diseasesATHEROGENICS INC·Filed 2002·Granted Aug 22, 2006·15 cites·39 claims
- 1878US6960683B2Salt forms of poorly soluble probucol esters and ethersATHEROGENICS INC·Filed 2003·Granted Nov 1, 2005·9 cites·59 claims
- 1972US7078431B21,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disordersATHEROGENICS INC·Filed 2003·Granted Jul 18, 2006·4 cites·73 claims
- 2071US7071158B2Antioxidant enhancement of therapy for hyperproliferative conditionsATHEROGENICS INC·Filed 2001·Granted Jul 4, 2006·13 cites·14 claims
- 2169US7273948B2Process of preparing esters and ethers of probucol and derivatives thereofATHEROGENICS INC·Filed 2004·Granted Sep 25, 2007·4 cites·55 claims
- 2268US6747061B2N-substituted dithiocarbamates for the treatment of biological disordersATHEROGENICS INC·Filed 2001·Granted Jun 8, 2004·4 cites·59 claims
- 2360US2007093453A1Sulfonamide-substituted chalcone derivatives and their use to treat diseasesATHEROGENICS INC·Filed 2006·Application pending·0 cites
- 2458US7173129B2Sulfonamide-substituted chalcone derivatives and their use to treat diseasesATHEROGENICS INC·Filed 2004·Granted Feb 6, 2007·0 cites·37 claims
- 2556US7183317B2Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionalityATHEROGENICS INC·Filed 2004·Granted Feb 27, 2007·1 cites·9 claims
- 2655US2006189581A1Compounds and methods for treating transplant rejectionATHEROGENICS INC·Filed 2006·Application pending·0 cites
- 2748US2005120396A1Human MEKK1 protein and nucleic acid molecules and uses thereforATHEROGENICS INC·Filed 2004·Application pending·0 cites
- 2843US7202247B21,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disordersATHEROGENICS INC·Filed 2002·Granted Apr 10, 2007·0 cites·25 claims
- 2943US2004019918A1Human MEKK2 protein and nucleic acid molecules and uses thereforATHEROGENICS INC·Filed 2003·Application pending·0 cites
- 3043US2003064496A1Human MEKK2 protein and nucleic acid molecules and uses thereforATHEROGENICS INC·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ATHEROGENICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →